drugset / Trial / NCT04936997
Immune Response to the COVID-19 Vaccine
NaSingle-groupOpen-labelTreatment
Summary
Explore the effects on immune response to include a potential third vaccine for the cancer cohort.
Timeline
- Start
- 2021-06-07
- Primary completion
- 2021-08-25
- Completion
- 2022-05-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BNT162b2 | Messenger RNA (mRNA) | — | — |